Patent · US Active

Compositions and methods for reducing C/EBP homologous protein activity in myeloid-derived suppressor cells

US9752145B2 · kind B2 · utility

1Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 16, 2015
Grant dateSep 5, 2017
Priority date
Expiry dateMar 16, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are compositions and methods of use thereof that modulate C/EBP homologous stress-related protein (Chop) activity in Myeloid-derived Suppressor Cells (MDSCs). Chop is a key point in the response of MDSCs to tumor-generated stress factors. In turn, the MDSCs release cytokines and other factors that function as immune suppressors, thereby allowing the tumors to thrive and expand. By inhibiting the level of Chop activity, the immunosuppressive function of MDSCs is disrupted. It has also been unexpectedly found that there is a concomitant increase in the ability of MDSCs to act as antigen-presenting and cytokine producing cells so as to act in increasing the efficacy of anti-tumor immune-based therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.